Nucleoside inhibitors of tick-borne encephalitis virus: structure-activity relationships and drug resistance study

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00027162%3A_____%2F18%3AN0000147" target="_blank" >RIV/00027162:_____/18:N0000147 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Nucleoside inhibitors of tick-borne encephalitis virus: structure-activity relationships and drug resistance study
Original language description
THE THIRD BAIKAL INTERNATIONAL SCIENTIFIC CONFERENCE ACTIVITIES, Irkutsk, Russian federation, 27.-29. 9. 2018 -lecture.Tick-borne encephalitis virus (TBEV) represents one of the most serious arboviral neuro-infection in Europe and northern Asia. As no specific antiviral therapy is available at present, there is an urgent need for efficient drugs to treat patients with TBEV infection. We report here a structure-activity relationship study based on the antiviral/cytotoxicity profile of 29 nucleoside derivatives, each differing in chemical substituents on the ribose ring and in the type and chemical modifications of the heterobase. In order to assess the acquired resistance of TBEV to 2´-C-methyl modified nucleosides, we isolated and characterized a drug-resistant TBEV mutant by serial in vitro passage of the Hypr TBEV strain on porcine stable kidney cells under the selective pressure of 7-deaza-2´-C-methyladenosine.
Czech name
—
Czech description
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)